Cargando…
The screening of pivotal gene expression signatures and biomarkers in renal carcinoma
Renal cell carcinoma (RCC) is one of the most common malignancies in the urinary system, among which the proportion of clear cell RCC (ccRCC) is over 80%. This study aims to explore potential signaling pathways and key biomarkers that drive RCC progression. The RCC GEO Datasets GSE15641 was featured...
Autores principales: | Ruan, Hailong, Li, Sen, Tong, Junwei, Cao, Qi, Song, Zhengshuai, Wang, Keshan, huang, Yu, Bao, Lin, Chen, Xuanyu, Yang, Hongmei, Chen, Ke, Zhang, Xiaoping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6856756/ https://www.ncbi.nlm.nih.gov/pubmed/31772671 http://dx.doi.org/10.7150/jca.30656 |
Ejemplares similares
-
ISG20 serves as a potential biomarker and drives tumor progression in clear cell renal cell carcinoma
por: Xu, Tianbo, et al.
Publicado: (2020) -
RAC2 acts as a prognostic biomarker and promotes the progression of clear cell renal cell carcinoma
por: Liu, Yuenan, et al.
Publicado: (2019) -
Overexpression of PLIN2 is a prognostic marker and attenuates tumor progression in clear cell renal cell carcinoma
por: Cao, Qi, et al.
Publicado: (2018) -
The Identification of Potential Biomarkers and Biological Pathways in Prostate Cancer
por: Song, Zhengshuai, et al.
Publicado: (2019) -
Long non-coding RNA Lucat1 is a poor prognostic factor and demonstrates malignant biological behavior in clear cell renal cell carcinoma
por: Xiao, Haibing, et al.
Publicado: (2017)